AdvaMed says no to yet another expedited device review process by US FDA
This article was originally published in RAJ Devices
Executive Summary
US medtech industry association AdvaMed believes the Food and Drug Administration should not use its limited resources for creating yet another pathway to expedite the approval of innovative medical devices1.